{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:06Z","timestamp":1793394966695,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC96-2321-B-320-003"],"award-info":[{"award-number":["NSC96-2321-B-320-003"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC97-2320-B-034-001-MY2"],"award-info":[{"award-number":["NSC97-2320-B-034-001-MY2"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC99-2320-B-034-003-MY3"],"award-info":[{"award-number":["NSC99-2320-B-034-003-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.nbd.2011.08.016","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T13:23:53Z","timestamp":1314451433000},"page":"322-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Ming-Chang","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijuang","family":"Chern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.08.016_bb0005","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0341341","article-title":"PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases","volume":"34","author":"Bordet","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2011.08.016_bb0010","doi-asserted-by":"crossref","first-page":"41452","DOI":"10.1074\/jbc.M303354200","article-title":"Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease","volume":"278","author":"Busch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.08.016_bb0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.08.016_bb0025","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.016_bb0030","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","article-title":"cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddl481","article-title":"Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease","volume":"16","author":"Chiang","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.016_bb0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1074\/mcp.M600356-MCP200","article-title":"Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach","volume":"6","author":"Chiang","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2011.08.016_bb0045","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","article-title":"The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system","volume":"18","author":"Chiang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.016_bb0050","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.016_bb0055","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbadis.2011.05.006","article-title":"The dysfunction of hepatic transcriptional factors in mice with Huntington's disease","volume":"1812","author":"Chiang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.08.016_bb0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.016_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.016_bb0070","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease","volume":"29","author":"Cummings","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.016_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington's disease","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.08.016_bb0080","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.016_bb0085","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.08.016_bb0090","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0095","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1074\/jbc.M700447200","article-title":"Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis","volume":"282","author":"Fuenzalida","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0100","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1124\/mol.106.033845","article-title":"The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells","volume":"71","author":"Ghosh","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2011.08.016_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/gad.1263305","article-title":"Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes","volume":"19","author":"Guan","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2011.08.016_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington's disease","volume":"41","author":"Hathorn","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.08.016_bb0115","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1210\/en.2006-0070","volume":"147","author":"Hondares","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2011.08.016_bb0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","article-title":"Huntington's disease: from pathology and genetics to potential therapies","volume":"412","author":"Imarisio","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2011.08.016_bb0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.016_bb0130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.08.016_bb0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.expneurol.2006.04.006","article-title":"PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease","volume":"199","author":"Landreth","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.016_bb0140","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPARgamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.016_bb0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.016_bb0150","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","article-title":"Huntington's disease. Pathogenesis and management","volume":"315","author":"Martin","year":"1986","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.nbd.2011.08.016_bb0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1alpha, a new therapeutic target in Huntington's disease?","volume":"127","author":"McGill","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.016_bb0160","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0165","doi-asserted-by":"crossref","first-page":"22464","DOI":"10.1074\/jbc.M800842200","article-title":"PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle","volume":"283","author":"Pagel-Langenickel","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.016_bb0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cyto.a.20033","article-title":"Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues","volume":"61","author":"Pendergrass","year":"2004","journal-title":"Cytom. A"},{"key":"10.1016\/j.nbd.2011.08.016_bb0180","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/B:NERE.0000018843.83770.4b","article-title":"Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation","volume":"29","author":"Perez-Severiano","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2011.08.016_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.nbd.2011.08.016_bb0190","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","article-title":"Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease","volume":"283","author":"Quintanilla","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0166-2236(99)01415-0","article-title":"Recent advances in understanding the pathogenesis of Huntington's disease","volume":"22","author":"Reddy","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.08.016_bb0200","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1023\/A:1025682611389","article-title":"Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases","volume":"28","author":"Rego","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2011.08.016_bb0205","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcb.20743","article-title":"Nuclear control of respiratory gene expression in mammalian cells","volume":"97","author":"Scarpulla","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0210","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.016_bb0215","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2011.08.016_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.016_bb0225","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuint.2006.03.020","article-title":"PPARgamma as a therapeutic target in central nervous system diseases","volume":"49","author":"Sundararajan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2011.08.016_bb0230","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.016_bb0235","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/oby.2008.326","article-title":"Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects","volume":"16","author":"Walker","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.nbd.2011.08.016_bb0240","doi-asserted-by":"crossref","first-page":"21379","DOI":"10.1074\/jbc.M109.018911","article-title":"PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons","volume":"284","author":"Wareski","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.016_bb0245","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/MCB.23.3.1085-1094.2003","article-title":"Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone","volume":"23","author":"Wilson-Fritch","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.08.016_bb0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.016_bb0255","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/11.9.1137","article-title":"Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin","volume":"11","author":"Wyttenbach","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.016_bb0260","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111002828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111002828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:41:22Z","timestamp":1714660882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111002828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0969996111002828"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.08.016","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2011.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}